DIALYSIS · CCN 492724

DaVita Annandale Dialysis

Annandale, VA 22003

DialysisProfitDaVita
$4.8M
TOTAL REVENUE
31.0%
OPERATING MARGIN
5 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.8M
Total costs
$3.3M
Operating income (rev − costs)
$1.5M
Operating margin
31.0%
Total charges
$4.9M
Total treatments
11,977
Dialysis stations
18

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.3648—
Fistula Rate
DFC_FISTULA_RATE
82.372—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.0951—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
85.766—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
672—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.2259—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
13.964—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
34.147—
Standardized ED Visits Ratio
DFC_SEDR
0.8539—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
29.232—